Stroke reduction with PPAR-Y antagonist pioglitazone

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Case-based learning and future directions
Case-based learning and future directions
MinuteCE®
Case-based learning and future directions
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Muthiah Vaduganathan, MD, MPH
- Jurgen Floege MD
1.00 program credit
MinuteCE®
Optimizing care for patients with CKM syndrome: a multidisciplinary approach
1.00 credit 4 episodes
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Jürgen Floege, MD
- Muthiah Vaduganathan, MD, MPH
1.00 credit 4 episodes
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD